Further characterization of human red blood cell membrane cholinergic receptors

Neuroprotective properties of glycosaminoglycans: potential treatment for neurodegenerative disorders.

Neuro-degenerative diseases·2008

Low intracerebroventricular doses of cholinotoxin AF64A do not affect the morphology of gonadotropin hormone-releasing hormone (GnRH)-immunoreactive fibers in the rat septum.

Brain research·2005

Glycosaminoglycan C3 protects against AF64A-induced cholinotoxicity in a dose-dependent and time-dependent manner.

Brain research·2004

Protective effect of the heparin-derived oligosaccharide C3, on AF64A-induced cholinergic lesion in rats.

Neurobiology of aging·2003

Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25-35)-induced abnormal tau protein immunoreactivity in rat brain.

Neurobiology of aging·2002

A ventral approach to stereotaxy of the guinea pig brain.

Journal of neuroscience methods·2000

The molecular geography of cell signaling diseases.

Molecular pharmacology·2026

Promotion of tumor cell senescence by the antibody-drug conjugate, sacituzumab govitecan.

Molecular pharmacology·2026

Molecular basis for state-dependent drug block of Kv11.1 (human ether-à-go-go-related gene) potassium channels.

Molecular pharmacology·2026

AKAP6β-a conductor in the orchestra of pathological cardiomyocyte gene transcription.

Molecular pharmacology·2026

ZD-4009, a novel B-cell lymphoma 9 inhibitor, is associated with ameliorated pulmonary fibrosis and reduced hypoxia-inducible factor 1α-mediated glycolysis and transforming growth factor-β/SMAD signaling.

Molecular pharmacology·2026

Piezo1 agonists are potent off-target inhibitors of the Kv1.3 channel via gating modification.

Molecular pharmacology·2026

Effective amyloid clearance with lecanemab in a female with Alzheimer's disease: A case report.

Radiology case reports·2026

On Serine Octamer Substitution Reactions.

Rapid communications in mass spectrometry : RCM·2026

Complete biosynthesis of the clinical agent escin Ia.

Nature communications·2026

Leishmania mitogen-activated protein kinases: Dynamic functionality and a pivotal player for therapeutic interventions The MAPK signalling landscape of Leishmania: structural diversity, biological functions and therapeutic potential.

Biochimie·2026

Integrative metabolomics and bioactivity profiling decipher the disparity between outer bark and parenchymatous tissue of Eriosema chinense Vogel root: Applications in enhancing shrimp shelf-life.

International journal of food microbiology·2026

Related Experiment Videos

Further characterization of human red blood cell membrane cholinergic receptors

Related Concept Videos

Neuroprotective properties of glycosaminoglycans: potential treatment for neurodegenerative disorders.

Low intracerebroventricular doses of cholinotoxin AF64A do not affect the morphology of gonadotropin hormone-releasing hormone (GnRH)-immunoreactive fibers in the rat septum.

Glycosaminoglycan C3 protects against AF64A-induced cholinotoxicity in a dose-dependent and time-dependent manner.

Protective effect of the heparin-derived oligosaccharide C3, on AF64A-induced cholinergic lesion in rats.

Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25-35)-induced abnormal tau protein immunoreactivity in rat brain.

A ventral approach to stereotaxy of the guinea pig brain.

The molecular geography of cell signaling diseases.

Promotion of tumor cell senescence by the antibody-drug conjugate, sacituzumab govitecan.

Molecular basis for state-dependent drug block of Kv11.1 (human ether-à-go-go-related gene) potassium channels.

AKAP6β-a conductor in the orchestra of pathological cardiomyocyte gene transcription.

ZD-4009, a novel B-cell lymphoma 9 inhibitor, is associated with ameliorated pulmonary fibrosis and reduced hypoxia-inducible factor 1α-mediated glycolysis and transforming growth factor-β/SMAD signaling.

Piezo1 agonists are potent off-target inhibitors of the Kv1.3 channel via gating modification.

Effective amyloid clearance with lecanemab in a female with Alzheimer's disease: A case report.

On Serine Octamer Substitution Reactions.

Complete biosynthesis of the clinical agent escin Ia.

Leishmania mitogen-activated protein kinases: Dynamic functionality and a pivotal player for therapeutic interventions The MAPK signalling landscape of Leishmania: structural diversity, biological functions and therapeutic potential.

Integrative metabolomics and bioactivity profiling decipher the disparity between outer bark and parenchymatous tissue of Eriosema chinense Vogel root: Applications in enhancing shrimp shelf-life.

Related Experiment Videos

Further characterization of human red blood cell membrane cholinergic receptors

Related Concept Videos

Related Articles